Trump Criticizes FDA For 'Slow' Approvals In Speech To Congress
Executive Summary
In his first address to a joint session of Congress, Trump spoke of a need to "slash the restraints" at US FDA and other regulatory agencies, and he reminded legislators about his executive order to eliminate two regulations for each new one written. The president's anti-regulatory posture comes as the White House is expected to seek budget cuts for domestic agencies.
You may also be interested in...
Gottlieb At FDA: Industry Will Look For User-Fee Deal Support, Restrained Regulations
After months of waiting on whether President Trump would pick a conventional FDA commissioner candidate or go off the beaten path, the White House appears to be taking the former approach. Trump is expected to nominate Scott Gottlieb, a George W. Bush administration FDA alum, physician and long-time conservative voice on health policy. Gottlieb will favor reduced regulatory burdens, and industry hopes he will help push forward a device user-fee reauthorization agreement.
GOP ACA-Replacement Draft: Device Tax Would Go Away; States Left To Decide Plan Coverage
Under a GOP Affordable Care Act "repeal and replacement" discussion draft, all ACA taxes – including the medical device tax – would be repealed, and each state would decide what minimum essential health benefits add up to acceptable health-care coverage.
AdvaMed Pushes For Trump To Address Device Tax In Joint-Session Address
As president Trump gets ready to make his first address before a joint session of Congress, the largest medical device lobby group is asking him to urge permanent repeal of the medical device tax. The group is also planning to blitz congressional offices this week in a bid to persuade lawmakers to include device-tax repeal in budget-reconciliation negotiations.